
Hertab 250mg Tablet - Shelf Life: 24 Months
Price: 560.00 INR / Pack
(500.00 INR + 12% GST)
Get Latest Price
MRP:
999.00 INR / Units
Weight :
150.00 Gram (G)
1 Pack Contains :
1
Minimum Pack Size :
50
In Stock
Product Specifications
| Indication | Anti Cancer Medication |
| Dosage Form | Tablets |
| Pacakaging (Quantity Per Box) | 30 Tablets Bottle Pack |
| Origin of Medicine | Chandigarh, Chandigarh, India |
| Salt Composition | LAPATINIB |
| Drug Type | Other Types |
| Physical Form | Tablets |
| Dosage | As prescribed by the physician |
| Dosage Guidelines | As prescribed by the physician |
| Suitable For | Women, Adults, Aged Person |
| Storage Instructions | Cool and dry place |
| Shelf Life | 24 Months |
| FOB Port | Product 473 |
| Payment Terms | Telegraphic Transfer (T/T) |
| Supply Ability | 500 Per Week |
| Delivery Time | 4 Days |
| Sample Available | No |
| Sample Policy | Contact us for information regarding our sample policy |
| Packaging Details | Pack Size : 150 TabletsPack Type : Box |
| Main Domestic Market | Chandigarh |
| Packsize | 1 |
| Unit Type | Units |
| Mop | 50 |
| Pkg Box Length | 2.00 Inches |
| Price Type | fixed |
| GSTIN | 12% |
| Stock Quantity | 50 |
| Weight | 150.00 Gram (G) |
| Pkg Box Height | 5.00 Inches |
| Shipping Type | actual |
| Currency | INR |
| Pkg Box Breadth | 2.00 Inches |
| Price | 500.00 INR (Approx.) |
| Returnable | No |
| Brand Name | Hetero |
| MRP | 999.00 INR |
| Minimum Ordered Packs | 50 |
Product Overview
Key Features
Type Of Medicines : Allopathic Dose Strength : 250mg Processing Type : Pharmaceutical Machine Prescription/Non Prescription : Prescription Application : Hospital, Clinic Supplier Location : Chandigarh, Chandigarh, India Hertab 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) It kills cancer cells and slows down their growth. Contains 250mg of Lapatinib Used for HER2-positive breast cancer treatment Oral tyrosine kinase inhibitor Targets HER2 and EGFR receptors Taken in combination with other cancer drugs Reduces cancer cell growth Convenient tablet form for daily use Prescribed for advanced or metastatic cancer Effective in hormone receptor-positive cases Supports long-term cancer management
Company Details
Sapra Healthcare is a dynamic and innovative multispecialty company committed to enhancing
human health and well-being through a diverse portfolio of pharmaceutical products, medical
devices, and nutraceuticals. Founded in 2023 and headquartered in Chandigarh and New Delhi,
India, Sapra Healthcare is driven by a mission to provide affordable and innovative healthcare
solutions to millions of people worldwide.
Business Type
Distributor, Supplier, Wholesaler
Employee Count
5
Establishment
2023
Working Days
Monday To Saturday
GST NO
04BPRPS0651G1ZR
Payment Mode
Cash in Advance (CID), Others
Certification
ISO 9001
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 04BPRPS0651G1ZR
Chandigarh, Chandigarh
CEO
Mr Jagmeet
Address
Shop 17, Village Dhanas, Sector 14, Chandigarh, Chandigarh, 160014, India
Report incorrect details


































